| 注册
首页|期刊导航|湖南中医药大学学报|血必净注射液联合常规西药治疗重症肺炎的临床疗效

血必净注射液联合常规西药治疗重症肺炎的临床疗效

李桂仙 程连房 张尧

湖南中医药大学学报2018,Vol.38Issue(3):342-344,3.
湖南中医药大学学报2018,Vol.38Issue(3):342-344,3.DOI:10.3969/j.issn.1674-070X.2018.03.027

血必净注射液联合常规西药治疗重症肺炎的临床疗效

Clinical Effect of Xuebijing Injection Combined with Conventional Western Medicine on Patients with Severe Viral Pneumonia

李桂仙 1程连房 1张尧1

作者信息

  • 1. 保定市第一中心医院重症医学科,河北 保定 071000
  • 折叠

摘要

Abstract

Objective To observe the clinical effect of Xuebijing injection combined with conventional Western medicine on patients with severe viral pneumonia. Methods Forty patients with severe pneumonia were randomly divided into the control group and observation group, 20 cases in each group. The patients in the two groups were given conventional Western medicine, such as ambroxol hydrochloride injection, doxofylline, nutrition support, anti-coagulant medicine, and the patients in the observation group were additionally given Xuebijing injection. The expression levels of WBC, hs-CRP, TNF-a, IL-5 were detected after treatment for 2 weeks. Results Before treatment, the levels of WBC, hs-CRP, TNF-α, IL-5 were not statistically sigiificant (P>0.05). After treatment for 2 weeks, the expression levels of WBC, hs-CRP, TNF-a, IL-5 in observation group decreased more significantly than the control group (P<0.05). The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). Conclusion Xuebijing injection combined with conventional Western medicine could significantly decrease in-flammatory factor levels in patients with severe pneumonia, and with good clinical efficacy.

关键词

血必净注射液/重症肺炎/炎症因子

Key words

Xuebijing injection/severe pneumonia/inflammatory factor

分类

医药卫生

引用本文复制引用

李桂仙,程连房,张尧..血必净注射液联合常规西药治疗重症肺炎的临床疗效[J].湖南中医药大学学报,2018,38(3):342-344,3.

湖南中医药大学学报

OACSTPCD

1674-070X

访问量0
|
下载量0
段落导航相关论文